CD4+ Cell Count in the HIV/AIDS-infected People with Pulmonary Complications

Pulmonary complications in HIV/AIDS patients. Introduction Pulmonary complications are very common during the course of Acquired Immunodeficiency Syndrome. (AIDS) Aim of the studyThe main study goal is to assess the patterns of respiratory complications in the HIV/AIDS patients Materials and methodsIn the study are enrolled 77 (83.1 %male HIV/AIDS) patients with pulmonary complications, with the mean age of the subjects was 46.410.2, , and known as HIV seropositive patients from 5.1 2.4. years. Data are elaborated by SPSS17 Results By occupational, 29 (37.7 %) were unemployed, 22 (28.6 %), employed, 5 (6.5 %), farmeres, 7 (9.1 %) office-beares, 14 (18.2 %). the others, regard to the count of CD4 cellules, 6 (7.8 %) from 300-399 cel/ml, 15 (19.5 %) with 200-300 cel/ml, 28 (36.4 %) patients from 100-199 cel/ml, and 28 (36.4 %) less than100cel/ml. In all of the patients (77) with HIV/AIDS are found 84 pulmonary manifestations, respectively bacterial pneumonia (first episode) in 12 (14.3 %) cases, recurent bacterial pneumonia-9 (10.6 %), pneumocystis carinii pneumonia (PCP) 33 (39, 3 %) cases, tuberculosis 27 (32.2 %), , divided in 23 (27.4 %) -cases as pulmonary tuberculosis and 4 (4.8 %) as generalised tuberculosis. Kaposy Syndrome- 2 (2.4 %), COPD -1 (1.2 %). cases. In the end of the study september 2015, 13 patients died, 12 of them had CD4 count level lower than CD4less than199/ml. We found a positive correlations between ages and mortality (p=.003), the pattern of pulmonary complications with CD4+ count level. Pless than0.0001. ConclusionsIn our study, the most common respiratory complications and with high mortality rate, are opportunistic infections from pneumocystis carinii pneumonia ( PCP) and tuberculosis ( TB). The level of CD4+ count is a useful indicator for developing respiratory infections and complications in HIV/AIDS patients.